Neuromyelitis optica is an inflammatory demyelinating disease of the central nervous system that differs from multiple sclerosis.Over the past 20 years,the search for biomarke rs for neuromyelitis optica has been ongo...Neuromyelitis optica is an inflammatory demyelinating disease of the central nervous system that differs from multiple sclerosis.Over the past 20 years,the search for biomarke rs for neuromyelitis optica has been ongoing.Here,we used a bibliometric approach to analyze the main research focus in the field of biomarkers for neuromyelitis optica.Research in this area is consistently increasing,with China and the United States leading the way on the number of studies conducted.The Mayo Clinic is a highly reputable institution in the United States,and was identified as the most authoritative institution in this field.Furthermore,Professor Wingerchuk from the Mayo Clinic was the most authoritative expe rt in this field.Keyword analysis revealed that the terms "neuro myelitis optica"(261 times), "multiple sclerosis"(220 times), "neuromyelitis optica spectrum disorder"(132 times), "aquaporin4"(99 times),and "optical neuritis"(87 times) were the most frequently used keywords in literature related to this field.Comprehensive analysis of the classical literature showed that the majority of publications provide conclusive research evidence supporting the use of aquaporin-4-IgG and neuromyelitis optica-IgG to effectively diagnose and differentiate neuromyelitis optica from multiple sclerosis.Furthermore,aquaporin-4-IgG has emerged as a highly specific diagnostic biomarker for neuromyelitis optica spectrum disorder.Myelin oligodendrocyte glycoprotein-IgG is a diagnostic biomarke r for myelin oligodendrocyte glycoprotein antibody-associated disease.Recent biomarkers for neuromyelitis optica in clude cerebrospinal fluid immunological biomarkers such as glial fibrillary acidic protein,serum astrocyte damage biomarkers like FAM19A5,serum albumin,and gammaaminobutyric acid.The latest prospective clinical trials are exploring the potential of these biomarkers.Preliminary results indicate that glial fibrillary acidic protein is emerging as a promising candidate biomarker for neuromyelitis optica spectrum disorder.The ultimate goal of future research is to identify non-invasive biomarkers with high sensitivity,specificity,and safety for the accurate diagnosis of neuro myelitis optica.展开更多
Evaluating the cluster formation of clinical attacks in chronic relapsing diseases is an important statistical issue because the presence of attack clusters may influence therapeutic strategies for relapse prevention....Evaluating the cluster formation of clinical attacks in chronic relapsing diseases is an important statistical issue because the presence of attack clusters may influence therapeutic strategies for relapse prevention.We recently reported the occurrence of unevenly clustered attacks in patients with anti-aquaporin-4(AQP4)antibody-positive neuromyelitis optica spectrum disorder(NMOSD)(Akaishi et al.,2020a).展开更多
目的探讨脑脊液白细胞介素10(interleukin 10,IL-10)在原发性中枢神经系统淋巴瘤(primary central nervous system lymphoma,PCNSL)中的诊断价值。方法收集作者医院2019-3-1—2022-12-31就诊并确诊的15例PCNSL患者、35例中枢神经系统脱...目的探讨脑脊液白细胞介素10(interleukin 10,IL-10)在原发性中枢神经系统淋巴瘤(primary central nervous system lymphoma,PCNSL)中的诊断价值。方法收集作者医院2019-3-1—2022-12-31就诊并确诊的15例PCNSL患者、35例中枢神经系统脱髓鞘疾病(inflammatory demyelinating diseases of the CNS,IDDs)患者和6例原发性中枢神经系统血管炎(primary central nervous system vasculitis,PCNSV)患者的临床资料,采用自动电化学发光免疫法检测各组患者血清和脑脊液白细胞介素6(IL-6)和IL-10水平,采用多组秩和检验分析组间血清和脑脊液IL-6、IL-10水平的差异,采用Spearman相关分析PCNSL患者脑脊液IL-10与患者性别、病变部位、年龄、病灶数目、病程、病灶的最大径、病灶的最大标准摄取值(SUVmax)之间的关系。结果与IDDs组和PCNSV组比较,PCNSL患者脑脊液IL-10水平升高(P<0.01);ROC分析结果显示,脑脊液IL-10鉴别诊断PCNSL的曲线下面积为1,以11.45 pg/mL为临界值,其诊断的敏感性和特异性均为100%;Spearman相关性分析结果显示,PCNSL患者脑脊液IL-10与患者性别、年龄、病灶数目、病程、病灶的最大径、SUVmax均无相关性(P>0.05)。结论针对无法取得脑活检且疑诊PCNSL的患者于治疗前进行IL-10检测具有重要意义,脑脊液IL-10升高强烈提示PCNSL的诊断。展开更多
文摘Neuromyelitis optica is an inflammatory demyelinating disease of the central nervous system that differs from multiple sclerosis.Over the past 20 years,the search for biomarke rs for neuromyelitis optica has been ongoing.Here,we used a bibliometric approach to analyze the main research focus in the field of biomarkers for neuromyelitis optica.Research in this area is consistently increasing,with China and the United States leading the way on the number of studies conducted.The Mayo Clinic is a highly reputable institution in the United States,and was identified as the most authoritative institution in this field.Furthermore,Professor Wingerchuk from the Mayo Clinic was the most authoritative expe rt in this field.Keyword analysis revealed that the terms "neuro myelitis optica"(261 times), "multiple sclerosis"(220 times), "neuromyelitis optica spectrum disorder"(132 times), "aquaporin4"(99 times),and "optical neuritis"(87 times) were the most frequently used keywords in literature related to this field.Comprehensive analysis of the classical literature showed that the majority of publications provide conclusive research evidence supporting the use of aquaporin-4-IgG and neuromyelitis optica-IgG to effectively diagnose and differentiate neuromyelitis optica from multiple sclerosis.Furthermore,aquaporin-4-IgG has emerged as a highly specific diagnostic biomarker for neuromyelitis optica spectrum disorder.Myelin oligodendrocyte glycoprotein-IgG is a diagnostic biomarke r for myelin oligodendrocyte glycoprotein antibody-associated disease.Recent biomarkers for neuromyelitis optica in clude cerebrospinal fluid immunological biomarkers such as glial fibrillary acidic protein,serum astrocyte damage biomarkers like FAM19A5,serum albumin,and gammaaminobutyric acid.The latest prospective clinical trials are exploring the potential of these biomarkers.Preliminary results indicate that glial fibrillary acidic protein is emerging as a promising candidate biomarker for neuromyelitis optica spectrum disorder.The ultimate goal of future research is to identify non-invasive biomarkers with high sensitivity,specificity,and safety for the accurate diagnosis of neuro myelitis optica.
文摘Evaluating the cluster formation of clinical attacks in chronic relapsing diseases is an important statistical issue because the presence of attack clusters may influence therapeutic strategies for relapse prevention.We recently reported the occurrence of unevenly clustered attacks in patients with anti-aquaporin-4(AQP4)antibody-positive neuromyelitis optica spectrum disorder(NMOSD)(Akaishi et al.,2020a).
文摘目的探讨脑脊液白细胞介素10(interleukin 10,IL-10)在原发性中枢神经系统淋巴瘤(primary central nervous system lymphoma,PCNSL)中的诊断价值。方法收集作者医院2019-3-1—2022-12-31就诊并确诊的15例PCNSL患者、35例中枢神经系统脱髓鞘疾病(inflammatory demyelinating diseases of the CNS,IDDs)患者和6例原发性中枢神经系统血管炎(primary central nervous system vasculitis,PCNSV)患者的临床资料,采用自动电化学发光免疫法检测各组患者血清和脑脊液白细胞介素6(IL-6)和IL-10水平,采用多组秩和检验分析组间血清和脑脊液IL-6、IL-10水平的差异,采用Spearman相关分析PCNSL患者脑脊液IL-10与患者性别、病变部位、年龄、病灶数目、病程、病灶的最大径、病灶的最大标准摄取值(SUVmax)之间的关系。结果与IDDs组和PCNSV组比较,PCNSL患者脑脊液IL-10水平升高(P<0.01);ROC分析结果显示,脑脊液IL-10鉴别诊断PCNSL的曲线下面积为1,以11.45 pg/mL为临界值,其诊断的敏感性和特异性均为100%;Spearman相关性分析结果显示,PCNSL患者脑脊液IL-10与患者性别、年龄、病灶数目、病程、病灶的最大径、SUVmax均无相关性(P>0.05)。结论针对无法取得脑活检且疑诊PCNSL的患者于治疗前进行IL-10检测具有重要意义,脑脊液IL-10升高强烈提示PCNSL的诊断。
文摘目的探讨免疫吸附对视神经脊髓炎谱系病(neuromyelitis optica spectrum disorder,NMOSD)急性期的治疗效果。方法对15例对大剂量糖皮质激素治疗反应不佳的NMOSD急性发作期患者,进行免疫吸附治疗5次,比较治疗前后的扩展残疾评分量表(expanded disability status scale,EDSS)、视力分层、水通道蛋白4(aquaporin 4,AQP4)抗体水平、免疫球蛋白及补体变化。结果15例患者免疫吸附治疗后相对于治疗前的EDSS评分〔4.0(3.0,6.0)比4.5(3.0,6.5),t=2.640,P=0.008〕、AQP4抗体水平〔(16.27±22.40)u/mL比(45.24±32.97)u/mL,t=4.011,P=0.002〕均显著降低。10例患者共15只眼出现视神经炎,治疗后视力均较治疗前显著改善〔视力分层4.0(3.0,5.0)比5.0(3.0,7.0),t=2.872,P=0.007〕。免疫吸附治疗后较治疗前补体C3水平〔(0.53±0.20)g/L比(1.02±0.22)g/L,t=6.588,P=0.001〕、补体C4水平〔(0.12±0.34)g/L比(0.20±0.06)g/L,t=5.597,P=0.001〕均显著下降。15例患者中5例出现轻度不良反应,4例患者在免疫吸附治疗3次后出现纤维蛋白原降低,经输注纤维蛋白原1 g 1次后改善;1例患者首次治疗中曾发生一过性低血压,补液治疗后缓解;无重度不良事件发生。结论免疫吸附治疗可有效改善NMOSD患者临床神经功能及视力,降低AQP4抗体水平。免疫吸附治疗安全性良好。